USP14/S100A11 axis promote colorectal cancer progression by inhibiting cell senescence
The aberrant expression of S100A11 has been identified in various malignancies but its functional roles and underlying mechanisms in colorectal cancer (CRC) have not been fully elucidated.
Zhaoying Wu +8 more
core +1 more source
Targeting SLC1A5-mediated glutamine metabolism overcomes PARP inhibitor resistance in ovarian cancer. [PDF]
Han F +6 more
europepmc +1 more source
VLX1570 suppresses neuroblastoma growth through inhibition of PCNA-associated proliferative signaling and potentiates cisplatin antitumor activity. [PDF]
Yang WH +14 more
europepmc +1 more source
Deubiquitinating enzymes-mediated post-translational modifications of ferroptosis regulates cancer drug resistance. [PDF]
Zhang L, Li M, Wang Y, Sun H, Lian H.
europepmc +1 more source
The role of deubiquitinating enzymes and their inhibitors in esophageal carcinoma (Review). [PDF]
Zhao Y, He C, Chen K, Sun N, He R, Li G.
europepmc +1 more source
Methylated GRP94 promotes liver fibrosis progression by enhancing endoplasmic reticulum stress. [PDF]
Liu X +6 more
europepmc +1 more source
Deubiquitinating Enzymes as Therapeutic Candidates in Hepatocellular Carcinoma and Other Liver Disease. [PDF]
Jeong YH +4 more
europepmc +1 more source
Deubiquitinating enzymes in kidney diseases: Molecular mechanisms, pathological roles and therapeutic opportunities (Review). [PDF]
Li Q, Ni Y, Li Z, Li J, Wang L.
europepmc +1 more source
Deubiquitinases as Regulators and Therapeutic Targets in Vascular Diseases. [PDF]
Lin ZK, Wang L.
europepmc +1 more source
ADORA2B, deubiquitinated by USP14, facilitates IL-1β-induced chondrocyte apoptosis, ferroptosis and inflammation to accelerate osteoarthritis process. [PDF]
Li Z, Zhang P, Ouyang C, Shen Z, Guo G.
europepmc +1 more source

